Butterfly Network

Butterfly Network (NYSE: BFLY) makes handheld ultrasound built on a semiconductor chip rather than traditional piezoelectric crystals — a single probe that images the whole body and plugs into a phone or tablet. Its differentiator is pairing that low-cost hardware with AI: guidance that helps less-experienced users capture correct images, and automated interpretation for defined tasks. In 2026 it received FDA clearance for a blind-sweep gestational-age AI, trained on tens of millions of images, that lets minimally trained users estimate fetal age — a meaningful global-health capability. With more than 150,000 devices deployed, Butterfly is a leading name in democratizing point-of-care ultrasound. As a listed company, its trajectory depends on translating device adoption and AI features into durable revenue.